Parkinson's in Women: How It's Different

A Semaine Health education guide. Reviewed against the published research; sources linked throughout. Educational content, not medical advice.

The short answer

Parkinson's disease is the exception that makes the "women's brains age differently" story honest: unlike Alzheimer's and most autoimmune conditions, Parkinson's is less common in women than men. Estrogen appears to be part of why, it seems to offer some protection to the brain circuits Parkinson's attacks. But "less common" doesn't mean "less important." Women with Parkinson's tend to be diagnosed later, experience the disease somewhat differently, and are undertreated in specific ways. Sex differences in the brain cut both directions, and this is the direction that favors women, with caveats worth knowing.

Why women get Parkinson's less often

According to a review of sex and gender differences in Parkinson's, the lower prevalence in women is not fully understood but may be partly explained by sex differences in the brain's nigrostriatal circuitry (the dopamine pathway Parkinson's degrades) and by possible neuroprotective effects of estrogen (Patel & Kompoliti, 2023, Neurologic Clinics; DOI). This fits the broader theme of the hub: estrogen acts as a brain regulator and protector (see how your brain runs on estrogen), and here that protection appears to lower a specific disease risk.

A more recent review focused specifically on sex and gender in Parkinson's adds nuance to this picture: it's not just estrogen exposure that matters, but the broader landscape of sex chromosomes and steroid hormones acting together on brain circuits throughout life, which is part of why the protective effect isn't simple or fully understood (Schaffner et al., 2025, Front Neuroendocrinol; DOI). Laboratory research on specific neuroactive steroids, hormone-derived compounds that act directly on brain cells, has similarly found some of these compounds protect the same dopamine-producing neurons that Parkinson's destroys, offering a plausible mechanistic thread connecting hormones to the disease at the cellular level (Bourque et al., 2023, Front Neuroendocrinol; DOI).

But women's Parkinson's is different, and under-served

The same review highlights that motor and non-motor symptoms differ between the sexes, and that women face disparities in care, including being less likely to receive deep brain stimulation (an effective treatment for some patients) and having less access to caregiving support (Patel & Kompoliti, 2023). This disparity has been directly measured: an analysis of Parkinson's patients eligible for deep brain stimulation found women were significantly less likely than men to actually receive the procedure, even after accounting for disease severity, a documented treatment gap rather than a general impression (Willis et al., 2013, Neurology; DOI). Women are also often diagnosed later. So the picture isn't simply "women are protected", it's "women get it less, but when they do, they're frequently under-recognized and under-treated."

What this means in practice

• Don't dismiss early signs. Because Parkinson's is stereotyped as a male disease, women's early symptoms (subtle tremor, stiffness, changes in handwriting or smell, sleep changes) can be overlooked. Early evaluation matters.
• Ask about the full range of treatment. If you or a loved one has Parkinson's, ask specifically about options like deep brain stimulation where appropriate, given the documented under-referral of women (Willis et al., 2013).
• Hormones are an open question. The role of estrogen and hormone therapy in Parkinson's is an active research area, not settled guidance, worth discussing with a neurologist rather than self-managing.

When to see a clinician

Persistent tremor, stiffness, slowed movement, a reduced sense of smell, or acting out dreams during sleep deserve evaluation by a clinician, ideally a neurologist. Parkinson's is highly manageable with the right care, and earlier diagnosis improves the path. This article is educational and not medical advice.

Frequently asked questions

Do women get Parkinson's less than men?

Yes. Parkinson's is less common in women, possibly due to differences in the brain's dopamine circuitry and the protective effects of estrogen and other sex hormones (Patel & Kompoliti, 2023; Schaffner et al., 2025). It's the opposite pattern from Alzheimer's.

Does estrogen protect against Parkinson's?

Research suggests estrogen and related neuroactive steroids may be neuroprotective for the dopamine-producing brain cells Parkinson's affects (Bourque et al., 2023), which could partly explain women's lower risk. The role of hormone therapy is still an open research question, not established treatment.

Is Parkinson's different in women?

Yes. Motor and non-motor symptoms can differ by sex, women are often diagnosed later, and a direct analysis found women are significantly less likely to receive deep brain stimulation than men with comparable disease severity (Willis et al., 2013), so under-recognition and under-treatment are real concerns.

What are early signs of Parkinson's in women?

Subtle tremor, stiffness, slowed movement, smaller handwriting, reduced sense of smell, and acting out dreams during sleep. Because Parkinson's is stereotyped as male, these can be missed in women, so raise them with a clinician.

Why is Parkinson's in this women's-brain hub if women get it less?

Because brain aging is sex-specific in both directions. Alzheimer's and autoimmune disease skew female; Parkinson's skews male. The unifying thread is that sex and estrogen shape brain risk, not that women face more of everything.

Related reading

• How your brain runs on estrogen
• Why are women more likely to get Alzheimer's?
• What is MCI (mild cognitive impairment)?

References

1. Bourque M, Morissette M, Di Paolo T. Neuroactive steroids and Parkinson's disease: review of the therapeutic potential. Front Neuroendocrinol. 2023. DOI: 10.1016/j.yfrne.2022.101040 · PubMed
2. Patel M, Kompoliti K. Sex and Gender Differences in Parkinson Disease. Neurol Clin. 2023. DOI: 10.1016/j.ncl.2022.12.001
3. Schaffner SL, et al. Sex and gender differences in Parkinson's disease pathophysiology. Front Neuroendocrinol. 2025. DOI: 10.1016/j.yfrne.2025.101153 · PubMed
4. Willis AW, Schootman M, Kung N, Racette BA. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 2013. DOI: 10.1212/WNL.0b013e3182a08d64 · PubMed